Bruker Corporation

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 21/07/2026 BST			5-day change	1st Jan Change
60.43 ^USD	+7.58%		+1.00%	+28.27%

07-15	Bruker Acquires Noscendo's Disqver Clinical Metagenomics Platform	MT
07-14	Bruker Corporation acquired DISQVER Clinical Metagenomics Platform of Noscendo GmbH.	CI

Published on 06/08/2026 at 02:52 pm BST - Modified on 07/02/2026 at 07:21 pm BST

S&P Capital IQ

Presenter Speech
Tycho Peterson (Analysts)

We're going to kick it off. I'm Tycho Peterson from the Healthcare Group. It's my pleasure to introduce Bruker. We've got Gerald with us. Welcome.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

07-15	Bruker Acquires Noscendo's Disqver Clinical Metagenomics Platform	MT
07-14	Bruker Corporation acquired DISQVER Clinical Metagenomics Platform of Noscendo GmbH.	CI
07-13	BofA Securities Adjusts Bruker Price Target to $70 From $65	MT
06-08	Bruker Corporation Presents at Jefferies Global Healthcare Conference 2026, Jun-04-2026 11:40 AM
06-04	Bruker Corporation Showcases Expanding Microbiology and Infection Diagnostics Portfolio at ASM Microbe 2026	CI
06-02	Bruker Corporation Launches New Timsmrms Mass Spectrometry Platform for Ultra-Complex Mixture Applications in the Energy Industry	CI
06-02	BofA Securities Adjusts Bruker Price Target to $65 From $49	MT
06-01	Bruker Corporation Launches Novel Mass Spectrometry Systems and Advances in 4D Proteomics and Metabolomics	CI
06-01	Analyst recommendations: Caesars Entertainment, Dell Technologies, AMD, Dycom Industries…
05-26	Bruker Corporation Commissions Novel Biospec 18 Tesla Preclinical Mri At Champalimaud Foundation	CI
05-13	Bruker Corporation announces Quarterly dividend, payable on July 07, 2026	CI
05-07	UBS Adjusts Price Target on Bruker to $45 From $40, Maintains Neutral Rating	MT
05-06	Bruker Corporation, Q1 2026 Earnings Call, May 06, 2026
05-06	Bruker Q1 Adjusted Earnings Fall, Revenue Rises; Maintains Fiscal 2026 Outlook	MT
05-06	(BRKR) Bruker Expects 2026 Revenue Range $3.57B - $3.6B, vs. FactSet Est of $3.58B	MT